In 2022, our university officially established the university-level "Health Innovation Center," with the aspiration to learn from the Microbiome Research Center at the University of New South Wales, Australia. Focusing on microbiome research, the center will particularly target diseases such as gastrointestinal cancers, metabolic syndrome, and rare metabolic disorders in children. By integrating microbiome, genomics, multiomics, phenomics, environmental factors, wearable device data, and other relevant big data, along with smart health care applications, we aim to develop personalized precision health for everyone. The goal is to predict and prevent the occurrence of diseases and carry out translational research in the field of health care, ultimately facilitating the practical application and effective implementation of research outcomes.
The overall goal
- Build a research and development ecosystem for precision health and health promotion throughout the entire life cycle, encompassing industry, academia, and research.
- Expand the research and development value of industry-academia innovation from basic to clinical, from laboratory to bedside care, and from hospitals to the community.
- Encourage cross-industry, cross-disciplinary, and cross-sector collaboration in health innovation research and development.
- Cultivate comprehensive key research and development talents for the national biomedicine and health industry in academia, research, and application.
- Connect with international benchmark innovation and research development paradigms, establishing a two-way collaborative exchange in academia and research.
Key development
- Investigate the role of the microbiota in digestive system cancers, metabolic syndrome, and rare metabolic disorders, as well as their pathogenic mechanisms. Develop microbiota-centered biomarkers and intervention strategies.
- Using the microbiota as the core, conduct multiomics and phenomics research on the mentioned diseases and their sub-healthy populations. Establish their digital avatars for disease prediction and prevention.
- The research mentioned above aims to develop a precision health research and development ecosystem that encompasses industry, academia, and research. This will expand the value of research and innovation from basic to clinical, from laboratory to patient care in hospital wards, and from hospitals to the community.
Specific objectives in the short, medium, and long term
1.Short-term objectives
- Researching the microbiome of diseases and sub-healthy populations.
- Researching multiomics and phenomics of diseases and sub-healthy populations.
- Developing health digital systems and intelligent cloud analytics, and optimizing disease proxy models.
2.Medium-term objectives
- Developing personalized predictive models and intervention strategies for disease prediction and prevention.
- Developing microbiome-related biomarkers and next-generation probiotic therapies for health promotion and disease prevention.
- Establishing personalized sub-healthy population proxy systems and intelligent cloud analytics systems.
3.Long-term objectives
- Achieving health promotion, health engagement, disease prediction, and disease prevention.
- Establishing a national-level health data integration and artificial intelligence inference engine smart platform.
- Cultivating outstanding and cross-disciplinary young scholars in advanced data algorithms and health innovation research.
- Establishing national-level research centers for multiomics and phenomics, microbiome research, and preventive medicine smart communication, and fostering related start-up companies.